SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Intellia Therapeutics Inc. (NTLA)

Add NTLA Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 5/10/2016 11:00:34 AM - Followers: 5 - Board type: Free - Posts Today: 0
Intellia Therapeutics, Inc. is a United States-based genome editing company focused on the development of curative therapeutics using a biological tool, CRISPR/Cas9 system. The Company's CRISPR/Cas9 technology edits diseased genes in the human body through a single treatment course. It focuses on the therapeutic applications of CRISPR/Cas9 genome editing. Its portfolio includes CRISPR/Cas9 platform technology, delivery technologies and nucleic acid modifications for human therapeutic use. The Company's CRISPR/Cas9 platform components include the guide ribonucleic acid (RNA) and the Cas9 nuclease (the genetic scissors). It has access to various delivery modalities specific to various in vivo and ex vivo approaches. The Company focuses on engineering ex vivo CRISPR/Cas9 cell therapies for chimeric antigen receptor T cell (CAR-T) and hematopoietic stem cell (HSC) applications. It also focuses on the use of in vivo Lipid Nanoparticle (LNP) delivery technology.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NTLA News: Intellia Therapeutics to Present Data at the European Society of Gene & Cell Therapy Congress 10/14/2016 07:00:00 AM
NTLA News: Intellia Therapeutics to Present at Jefferies Gene Editing/Therapy Summit 10/05/2016 07:00:00 AM
NTLA News: Intellia Therapeutics to Present at September Investor Healthcare Conferences 09/01/2016 07:00:00 AM
NTLA News: Intellia Therapeutics’ Preclinical Data Show Continued Progress in In Vivo Gene Editing With Systemic Lipid Nanoparticle De... 08/18/2016 09:37:30 PM
NTLA News: Intellia Therapeutics to Present at 2016 Wedbush PacGrow Healthcare Conference 08/10/2016 04:05:00 PM
#1   Took a starter here, CRISPR could do amazing things! rule_rationale 05/10/16 11:00:34 AM